Vericel Corp. (VCEL)
38.58
+1.20
(+3.21%)
USD |
NASDAQ |
Jun 11, 14:48
Vericel Debt to Equity Ratio : 0.2707 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.2707 |
| December 31, 2025 | 0.2771 |
| September 30, 2025 | 0.3101 |
| June 30, 2025 | 0.3309 |
| March 31, 2025 | 0.3416 |
| December 31, 2024 | 0.342 |
| September 30, 2024 | 0.3795 |
| June 30, 2024 | 0.3942 |
| March 31, 2024 | 0.3946 |
| December 31, 2023 | 0.3901 |
| September 30, 2023 | 0.4162 |
| June 30, 2023 | 0.4193 |
| March 31, 2023 | 0.2417 |
| December 31, 2022 | 0.2476 |
| September 30, 2022 | 0.2706 |
| June 30, 2022 | 0.2756 |
| March 31, 2022 | 0.2856 |
| December 31, 2021 | 0.2944 |
| September 30, 2021 | 0.3244 |
| June 30, 2021 | 0.3418 |
| March 31, 2021 | 0.3742 |
| December 31, 2020 | 0.397 |
| September 30, 2020 | 0.2417 |
| June 30, 2020 | 0.2471 |
| March 31, 2020 | 0.2468 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.2507 |
| September 30, 2019 | 0.2917 |
| June 30, 2019 | 0.3087 |
| March 31, 2019 | 0.0016 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.1829 |
| June 30, 2018 | 0.1906 |
| March 31, 2018 | 0.8238 |
| December 31, 2017 | 0.7648 |
| September 30, 2017 | 0.5949 |
| June 30, 2017 | 0.7273 |
| March 31, 2017 | 0.1999 |
| December 31, 2016 | 0.4099 |
| September 30, 2016 | 0.4922 |
| June 30, 2016 | 0.1377 |
| March 31, 2016 | 0.0032 |
| December 31, 2015 | 0.0032 |
| September 30, 2015 | 0.0031 |
| June 30, 2015 | 0.003 |
| March 31, 2015 | 0.0032 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.004 |
| June 30, 2014 | 0.8977 |
| March 31, 2014 | 0.0005 |
| December 31, 2013 | 0.0015 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Marker Therapeutics, Inc. | 0.00 |
| Krystal Biotech, Inc. | 0.0071 |
| TG Therapeutics, Inc. | 1.292 |
| Gyre Therapeutics, Inc. | 0.0081 |
| ACADIA Pharmaceuticals, Inc. | 0.0407 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 485.63M |
| Total Liabilities (Quarterly) | 129.40M |
| Shareholders Equity (Quarterly) | 356.23M |
| Current Ratio | 5.176 |
| Net Debt Paydown Yield | 0.04% |